e-learning
resources
Virtual 2021
07.09.2021
Molecular pathology and cell biology of pulmonary diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lipopolysaccharide (LPS) treatment enhances the regenerative capacity of mesenchymal stromal cells-derived exosomes
A. Areny Balagueró (Sabadell, Spain), M. Camprubí Rimblas (Sabadell, Spain), R. Guillamat Prats (Sabadell, Spain), L. Blanch (Sabadell, Spain), A. Roig (Bellaterra, Spain), D. Closa (Barcelona, Spain), A. Artigas (Sabadell, Spain)
Source:
Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Session:
Molecular pathology and cell biology of pulmonary diseases
Session type:
E-poster
Number:
3617
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Areny Balagueró (Sabadell, Spain), M. Camprubí Rimblas (Sabadell, Spain), R. Guillamat Prats (Sabadell, Spain), L. Blanch (Sabadell, Spain), A. Roig (Bellaterra, Spain), D. Closa (Barcelona, Spain), A. Artigas (Sabadell, Spain). Lipopolysaccharide (LPS) treatment enhances the regenerative capacity of mesenchymal stromal cells-derived exosomes. 3617
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Extracellular vesicles derived from mesenchymal stem cells prevent pulmonary vascular dysfunction induced by lipopolysaccharide (LPS).
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018
Adrenaline stimulated mesenchymal stem cells modulate inflammation in lipopolysaccharide induced lung injury
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012
Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012
Pro-inflammatory stimuli affect the production of cytokines and growth factors by human bone marrow-derived mesenchymal stem cells
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Lung-derived mesenchymal stem cells induce the secretion of hepatocyte growth factor in fibroblasts
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Oral Presentation: TGF-beta1 regulates the epithelial supportive capacity of mesenchymal stromal cells
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012
Protective effect of mesenchymal stem cells (MSC) on hypoxia-induced epithelial-mesenchymal transition of alveolar epithelial cells (AEC)
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012
Inflammatory response and epithelial-mesenchymal transition based on the model of co-cultured alveolar epithelial cells and monocytes induced by lipopolysaccharide.
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
Impaired angiogenic supportive capacity and altered gene expression profile of CD146 mesenchymal stromal cells isolated from hyperoxia-injured neonatal rat lungs
Source: ERS Lung Science Conference 2018
Year: 2018
Aerosolised delivery of mesenchymal stromal cells to the lungs: towards a novel therapy
Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions
Year: 2017
Induced pluripotent stem cell-derived alveolar epithelial cells: applications with lung-on-a-chip
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019
Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019
The secretome of lung resident mesenchymal stem cells is anti-fibrotic in vitro and in vivo
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
Mesenchymal stromal cells and macrophages in sepsis: new insights
Source: Eur Respir J, 51 (4) 1800510; 10.1183/13993003.00510-2018
Year: 2018
Efficient gene transduction of adipose tissue-derived mesenchymal stem cells (MSCs) for asthma research
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011
Characterisation and hepatocyte-like differentiation of mesenchymal stem cells derived from adipose tissue of immunodeficient mice
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012
Electroporation of Hepatocyte growth factor to the lung induces migration of bone marrow mesenchymal stem cells and reduces lung fibrosis
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept